BOOG 2013-08: Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up.

Recruiting

• Conditions: breast neoplasms; breast conserving therapy.; breast cancer; sentinel lymph node biopsy

• Registration Number: NL-OMON22593
• Lead Sponsor: KWFCZZonMw

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 1644

Inclusion Criteria

1. Female

2. Aged 18 years or older

Exclusion Criteria

1. Clinically node positive pre-operative

2. Bilateral breast cancer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Regional recurrence rate after 5- and 10 years of follow-up.

Secondary Outcome Measures

Name	Time	Method
Distant-disease free survival, overall survival, delayed axillary lymph node dissections, axillary morbidity, quality of life, local recurrence, contralateral breast cancer, and percentage difference in administered (neo)adjuvant systemic therapy after 5- and 10 years of follow-up.